on EUROPLASMA (EPA:ALEUP)
EUROPLASMA: 2025 Annual Results
In 2025, Europlasma recorded a €28.0 million increase in revenue, driven by the defense and rail sectors, as well as the integration of FDB Industries. Despite this increase, EBITDA fell to -€19.8 million due to operational constraints and increased expenses. In April 2026, a €45 million bond financing was secured to support the group's development. The sale of the defense-related activities is under discussion, while Satma Industries and FP Industries are facing legal proceedings. The group remains in an uncertain position regarding its going concern status due to potentially unfavorable market conditions.
R. H.
Copyright © 2026 FinanzWire, all reproduction and representation rights reserved.
Disclaimer: although drawn from the best sources, the information and analyzes disseminated by FinanzWire are provided for informational purposes only and in no way constitute an incentive to take a position on the financial markets.
Click here to consult the press release on which this article is based
See all EUROPLASMA news